MUC1 and neoplasm: In GC, the presence of the altered glycosylation of MUC1 in tumor microenvironment pathway (WP4480) (BH = 2.82E-04), linked to the tumor microenvironment is clearly related to the pathology (Hinshaw and Shevde 2019) with 7 genes and the EPO receptor signaling pathway (WP581) (BH = 2.82E-04), with 14 genes.